Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06860152 · ClinicalTrials.gov registry record · NA
Cochlear Implant Speech in Noise Processing
A NA study of Hearing Loss, Adult-Onset and Speech Intelligibility, sponsored by Phillip Gander.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 1
- Study location
NCT06860152: Recruiting NA study of Hearing Loss, Adult-Onset and Speech Intelligibility, sponsored by Phillip Gander.
NCT06860152 is a NA study of Hearing Loss, Adult-Onset and Speech Intelligibility that is actively recruiting participants, run by Phillip Gander. The registered enrollment target is 150 participants, below the 190-participant average among 3 other Hearing Loss, Adult-Onset trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06860152, a NA study of Hearing Loss, Adult-Onset and Speech Intelligibility, is actively recruiting participants, sponsored by Phillip Gander.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will help us in understanding the neural mechanisms by which listeners with a cochlear implant detect speech in noisy environments.
Primary Outcome
PET imaging will be used to identify the brain regions for listeners ability to recognize speech in noise at different signal-to-noise ratios.
Conditions Studied
Interventions
- DEVICE Cochlear implant
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-11-14 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06860152 shows while recruiting
NCT06860152 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 190-participant average among 3 other Hearing Loss, Adult-Onset trials with a reported enrollment target (21% lower).
The record links to 3 conditions, with Hearing Loss, Adult-Onset appearing as the primary indexed condition, and to 1 intervention - of which Cochlear implant is the first listed.
NCT06860152 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT06860152 about?
NCT06860152 is a clinical study titled "Cochlear Implant Speech in Noise Processing". The study will help us in understanding the neural mechanisms by which listeners with a cochlear implant detect speech in noisy environments.
What is the current status of trial NCT06860152?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-11-14. Estimated completion is 2028-03-31.
What conditions does trial NCT06860152 study?
This clinical trial studies the following conditions: Hearing Loss, Adult-Onset, Speech Intelligibility, Hearing Loss, Extreme.
What interventions are being tested in trial NCT06860152?
The interventions under investigation include: Cochlear implant (DEVICE).
Who is sponsoring clinical trial NCT06860152?
This trial is sponsored by Phillip Gander, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06860152 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Loss, Adult-Onset
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI